Description of new cytochrome P450 2D6 (CYP2D6) alleles resulting from aberrant crossover between CYP2136 and CYP2D7

被引：0
|
作者：
Kramer, Whitney E.
Dukek, Brian A.
Bruflat, Jamie K.
Walker, Denise A.
O'Kane, Dennis J.
Mrazek, David A.
Black, John Logan
机构：
[1] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA
[2] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Psychiat, Psychol Psychogenom Lab, Rochester, MN USA
来源：
BIOLOGICAL PSYCHIATRY | 2007年 / 61卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
408
引用
收藏
页码：126S / 126S
页数：1
相关论文
共 50 条
  • [21] Persistent mood disorders and cytochrome P450 2D6:: influence of the CYP2D6 gene duplication on the development of persistence
    Kawanishi, C
    Ågren, H
    Bertilsson, L
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 180 - 180
  • [22] Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding
    Wang, An
    Stout, C. David
    Zhang, Qinghai
    Johnson, Eric F.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (08) : 5092 - 5104
  • [23] Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity
    Magliocco, Gaelle
    Desmeules, Jules
    Matthey, Alain
    Quiros-Guerrero, Luis M.
    Bararpour, Nasim
    Joye, Timothee
    Marcourt, Laurence
    Queiroz, Emerson F.
    Wolfender, Jean-Luc
    Gloor, Yvonne
    Thomas, Aurelien
    Daali, Youssef
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (23) : 4708 - 4725
  • [24] Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
    M Ingelman-Sundberg
    The Pharmacogenomics Journal, 2005, 5 : 6 - 13
  • [25] The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence on clinical outcomes in psychiatry
    Chen, SQ
    Chou, WH
    Blouin, RA
    Mao, ZP
    Humphries, LL
    Meek, C
    Neill, JR
    Martin, WL
    Hays, LR
    Wedlund, PJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (05) : 522 - 534
  • [26] Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects
    Gaedigk, A
    Ndjountché, L
    Gaedigk, R
    Leeder, JS
    Bradford, LD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) : 575 - 576
  • [27] Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population
    Salyakina, Daria
    Roy, Sharmeen
    Wang, Weize
    Oliva, Mailin
    Akhouri, Rohan
    Sotto, Ileana
    Mulas, Nicole
    Solano, Rafaela
    Fernandez, Jose R.
    Sanchez, Stephanie
    Shamshad, Uzma
    Perlyn, Chad
    McCafferty-Fernandez, Jennifer
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (09):
  • [28] Fluoxetine inhibits cytochrome P450 2D6 (CYP2D6)-mediated metabolism of propafenone in healthy Chinese volunteers
    Reactions Weekly, 2000, 785 (1) : 3 - 3
  • [29] CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6*15 and*35 Genotyping
    Riffel, Amanda K.
    Dehghani, Mehdi
    Hartshorne, Toinette
    Floyd, Kristen C.
    Leeder, J. Steven
    Rosenblatt, Kevin P.
    Gaedigk, Andrea
    FRONTIERS IN PHARMACOLOGY, 2016, 6
  • [30] The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine
    Davis, MP
    Homsi, J
    SUPPORTIVE CARE IN CANCER, 2001, 9 (06) : 442 - 451
12345